PMV Pharmaceuticals, Inc.
Develops small molecule therapies to restore the function of mutated p53 tumor suppressors.
PMVP | US
Overview
Corporate Details
- ISIN(s):
- US69353Y1038
- LEI:
- Country:
- United States of America
- Address:
- 400 ALEXANDER PARK DRIVE, 8540 PRINCETON
- Website:
- https://www.pmvpharma.com/
- Sector:
- Manufacturing
Description
PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule, tumor-agnostic therapies. The company's research centers on the p53 tumor suppressor protein, which is mutated in approximately half of all human cancers. PMV Pharmaceuticals develops first-in-class drug candidates, referred to as p53 regulators, designed to selectively target these mutations. The company's therapeutic approach aims to structurally correct the mutated p53 protein, thereby restoring its normal, wild-type tumor-suppressing function to treat various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PMV Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PMV Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PMV Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
